Skip to main content
EJNMMI Research
Fig. 1 | EJNMMI Research

Fig. 1

From: Targeted scVEGF/177Lu radiopharmaceutical inhibits growth of metastases and can be effectively combined with chemotherapy

Fig. 1

Growth of 4T1luc mouse breast carcinoma metastatic lesions in syngeneic Balb/c mice. a Representative longitudinal whole body BLI performed during 13 days after intracardiac injection of 4T1luc cells. Prior to imaging mice received lucefirin (0.5 mg/mouse, intraperitonially). b Representative CT imaging of metastatic bone lesions at day 13 after 4T1luc injection. Blue arrows indicate metastatic lesions. Red cross marks left hind leg. c MicroCT image of right and left hind leg knee. Areas of significant pitting and large areas of osteolysis associated with bone metastatic lesions are visible around knee joints

Back to article page